亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Methods for Producing and Using Polymyxins (Colistins A and B)

詳細技術說明
Application(Product)Highyield production of Colistins A and BProblemsAddressed    (benefits/advantages)Increasing antibiotic resistance in bacteria presents a criticalproblem for public health. Limited therapeutic options have forced infectiousdisease clinicians and microbiologists to reappraise the clinical applicationof relatively old polymyxin antibiotics, thus creating an increased need forthis class of com-pounds. Resistance to polymyxin (aka Colistin) is currentlyvery rare, rendering attractive their use against certain bacterial strains.Nevertheless, in vitro, polymyxin has had excellent activity against a varietyof gram-negative bacteria, including those that are resistant to other classesof antimicrobials (e.g., penicillin and amino glycosides).Polymyxins are also used to neutralize or absorb LPS contaminatingsamples that are intended for use in e.g. immunological experiments.Minimization of LPS contamination can be important because LPS can evoke strongreactions from immune cells and therefore distort experimental results.Outside the medical and veterinary arenas, the use of antibioticsby biotech/biopharma as additives to biofermentation mixtures is a ubiquitousmeans to eliminate contamination of broth by extraneous microorganisms.
*Abstract

UGA investigators havedeveloped a technique that provides a novel source for antibiotics with broadspectrum activity against both Gram-positive and -negative bacteria.

Additionally five isolatesof the organism used to produce colistins inhibited growth of both E. coli andS. aureus.

 

Advantages

    • Efficient three-step purification protocol

    • Produces antibacterial compounds  identical to commercial antibiotics as well asadditional antibacterial compounds with activity against Gram-positive bacteria

    • High yield  

       

Potential Applications

    •  Production andpurification of antimicrobials in large scale from simple culture media

  •           In the competitive exclusion (CE) of organisms such as 

    foodpathogens

  • As an additive to probiotics for farm animals

  • Inventor

    • Dr.Joy D. Peterson

       

    TechnologyDevelopment and IP Status

    Production in lab scale hasbeen optimized.

    Issued US Patent  7,935, 503

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備